Docket #: S10-206
A diagnostic method for identifying immune system decline
A team of Stanford researchers have identified a set of biomarkers that could be used to recognize patients with age-related declines in their immune function. This Immune Senescence Signature (ISS) was characterized by analyzing peripheral blood cells from young and old adults and measuring cell subset frequencies, serum cytokines, gene expression, and response to cytokine stimulation. This data was then used to construct an immune network and characterize a cytokine non-responsive phenotype (CNR) based on the relationship between multiple factors in single individuals. ISS screening to identify patients with sub-functional immune system could be used to introduce measures for reducing their risk of morbidity or mortality from infectious diseases.
Applications
- Diagnostic screening for immune function of healthy individuals, especially elderly
Advantages
- Comprehensive range of biomarkers - the combination of several biomarkers yields more accurate assessment of immune function than assays focused on a single marker
Patents
- Published Application: 20120021414
- Issued: 10,119,959 (USA)
Similar Technologies
-
Non-invasive Blood Test for Diagnosing Crohn's Disease and Ulcerative Colitis S18-217Non-invasive Blood Test for Diagnosing Crohn's Disease and Ulcerative Colitis
-
BCL11B as a Biomarker for Breast Cancer Patients to Improve Chemotherapy Efficacy Utilizing TNF-? Treatment S24-165BCL11B as a Biomarker for Breast Cancer Patients to Improve Chemotherapy Efficacy Utilizing TNF-? Treatment
-
Gene Set for the Diagnosis of Active Pulmonary Tuberculosis S15-057Gene Set for the Diagnosis of Active Pulmonary Tuberculosis